Table 71.1.
Agents of concern for use in bioterrorism
Highest priority: category A (based upon potential mortality, morbidity, virulence, transmissibility, aerosol feasibility and psychosocial implications of an attack) | |
---|---|
Microbe/toxin | Disease |
Bacillus anthracis | Anthrax: inhalational, cutaneous |
Variola virus | Smallpox and its variants |
Yersinia pestis | Plague: pneumonic, bubonic, septicemic |
Clostridium botulinum toxin | Botulism |
Francisella tularensis | Tularemia: pneumonic, typhoidal |
Viral hemorrhagic fevers | |
Filoviruses | Ebola, Marburg |
Arenaviruses | Lassa fever, South American hemorrhagic fevers |
Bunyaviruses | Rift Valley fever, Congo–Crimeanhemorrhagic fever |
Flaviviruses | Dengue |
Moderately high priority: category B (based upon potential morbidity, aerosol feasibility, dissemination characteristics, and diagnostic difficulty) | |
---|---|
Microbe/toxin | Disease |
Coxiella burnetti | Q fever |
Brucella spp. | Brucellosis |
Burkholderia mallei | Glanders |
Burkholderia pseudomallei | Melioidosis |
Alphaviruses (e.g. EEE, VEE) | Viral encephalitides |
Ricinus communis toxin | Ricin intoxication |
Staphylococcal enterotoxin B | Staphylococcal toxin illness |
Salmonella spp., Shigella dysenteriae, Escherichia coli O157:H7, Vibrio cholerae,Cryptosporidiumparvum, Listeria monocytogenes, Campylobacter, jejuni, Yersinia enterocolitica | Food- and waterborne gastroenteritis |
Rickettsia prowazekii | Epidemic typhus |
Chlamydiapsittaci | Psittacosis |
Epsilon toxin of Clostridium perfringens | C. perfringens intoxication |
Emerging threat agents: category C (based upon potential for production and dissemination, availability, morbidity/mortality) | |
---|---|
Microbe/toxin | Disease |
Hantaviruses | Viral hemorrhagic fevers |
Flaviviruses | Yellow fever, West Nile virus |
Mycobacterium tuberculosis | Multidrug-resistant tuberculosis |
Nipah virus | Systemic flu-like illness |
Miscellaneous (other examples of candidate threat agents that possess some elements of bioterrorism concern) | |
---|---|
Genetically engineered vaccine- and/or antimicrobial-resistant category A or B agents | |
HIV-1 | |
Adenoviruses | |
Influenza | |
Rotaviruses | |
Molecular hybrid pathogens (e.g. smallpox–plague, smallpox–ebola) | |
Severe acute respiratory syndrome coronavirus |
EEE, eastern equine encephalomyelitis; VEE, Venezuelan equine encephalomyelitis.
Adapted from Patrozou & Artenstein.26